Celadon Pharmaceuticals plc is a UK based pharmaceutical company targeting the research, cultivation, manufacturing and supply of cannabinoid-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabinoid-based medicines for other conditions such as autism. Its UK facility comprises a laboratory designed to meet UK-GMP standards, and capacity for a large indoor hydroponic growing facility that has received a Home Office Licence to legally grow high THC medicinal cannabis for the purpose of producing test batches of cannabis oil to support its application to the MHRA. The Company’s subsidiary, LVL, owns a MHRA conditionally approved cannabis trial using cannabis based medicinal products to treat chronic pain in the UK.
Celadon Pharmaceuticals plc
Researcher and manufacturer of cannabinoid-based medicines
Company information
Company:
Public
Fund:
AIM EIS Fund, EIS Portfolio Service, Growth Capital VCT
Sector:
Pharma
Status:
Exited
Investment Date:
03/2022
You might also be interested in...
Clinical stage biotech company with a focus on the prevention of life-threatening infections